NCT04510103

Brief Summary

Dry skin is characterized by a lack of moisture in the outer layer of the skin and can occur as a result of numerous factors including cold weather, low humidity, age, etc. In this study, the moisturizing benefits of two formulas were evaluated for barrier function improvement/impact when used by women with moderately to severely dry skin on their lower legs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2016

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2016

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

August 10, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 12, 2020

Completed
Last Updated

August 12, 2020

Status Verified

August 1, 2020

Enrollment Period

5 months

First QC Date

August 10, 2020

Last Update Submit

August 10, 2020

Conditions

Keywords

SkinStratum CorneumSkin CareSkin CreamDrynessMoisturizationHydration

Outcome Measures

Primary Outcomes (1)

  • Mean Change from Baseline to Week 6 in Clinical Grading of Skin Dryness

    The investigator assessed each of the subject's lower legs for skin dryness on a scale of 0 (no dryness) to 4 (severe scaling/fissuring). Half-points allowed.

    Baseline to Week 6

Secondary Outcomes (59)

  • Mean Change from Baseline to Week 2 in Clinical Grading of Skin Dryness

    Baseline to Week 2

  • Mean Change from Baseline to Week 4 in Clinical Grading of Skin Dryness

    Baseline to Week 4

  • Mean Change from Regression Baseline to Regression Day 1 in Clinical Grading of Skin Dryness

    Regression Baseline to Regression Day 1

  • Mean Change from Regression Baseline to Regression Day 4 in Clinical Grading of Skin Dryness

    Regression Baseline to Regression Day 4

  • Mean Change from Regression Baseline to Regression Day 7 in Clinical Grading of Skin Dryness

    Regression Baseline to Regression Day 7

  • +54 more secondary outcomes

Study Arms (2)

Regression Group

OTHER

The Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then entered a 2-week regression period (no moisturizer usage).

Drug: Moisturizer A, F#9155-005Other: Moisturizer B, F#E1387-004Procedure: Regression

Non-Regression Group

OTHER

The Non-Regression Group received the two test moisturizers to use split-leg (right vs. left lower leg randomized) for 6 weeks and then underwent a physical insult (tape stripping) on the lower legs and continued using the moisturizer for 4 additional days.

Drug: Moisturizer A, F#9155-005Other: Moisturizer B, F#E1387-004Procedure: Non-Regression

Interventions

OTC Monograph Drug. Used twice daily on left or right lower leg per randomization schedule.

Non-Regression GroupRegression Group

Cosmetic Moisturizer. Used twice daily on left or right lower leg per randomization schedule.

Non-Regression GroupRegression Group
RegressionPROCEDURE

2 week regression period after 6 weeks of moisturizer use.

Regression Group

Physical insult (tape stripping) on the lower leg after 6 weeks of moisturizer use.

Non-Regression Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • moderately to severely dry skin on both leg legs, as determined by the investigator.
  • Fitzpatrick skin types I-IV
  • generally in good health
  • routinely uses moisturizers on the legs at least 1-3 times per week.
  • if of reproductive potential: using a medically acceptable form of birth control for at least 3 months before the study and willing to continue it for at least 1 month after study completion.
  • able to read, write, speak, and understand English.
  • willing and able to complete all study instructions.
  • has completed the informed consent document including a HIPAA disclosure and photograph release.

You may not qualify if:

  • known allergies/sensitivities to adhesive tapes or study product ingredients.
  • known skin conditions, uncontrolled medical conditions, or any other condition that could interfere with evaluations/data interpretation or increase risk to the subject.
  • any active bacterial/fungal/viral skin infections or susceptibility to such infections.
  • females who are pregnant, breastfeeding, or planning to become pregnant in near future.
  • compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk to the subject.
  • current participation in another study.
  • participation in another study in past 4 weeks.
  • employees or relatives of the investigator or study site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thomas J. Stephens & Associates, Inc.

Colorado Springs, Colorado, 80915, United States

Location

Study Officials

  • Neena Tierney

    Johnson & Johnson Consumer Inc. (J&JCI)

    STUDY DIRECTOR
  • Kun "Mark" Qian, M.D.

    Thomas J. Stephens & Associates, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The test moisturizers were assigned a product code; each moisturizer was assigned to a subject's right or left lower leg per a randomization schedule. Subjects were blinded to the product identities, and evaluators were blinded to which product was used on each leg. Procedural group was unblinded and based on scheduling at Visit 1.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Subjects were assigned to one of two procedural groups (Regression or Non-Regression) based on Visit 1 scheduling. Subjects were provided with a commercial cleanser to use during a 3-day period with no moisturizers and no hair removal allowed on their lower legs, and to continue using throughout the study. At Visit 2, all subjects received the two test moisturizers to use split-leg (right vs. left lower leg randomized) to use for 6 weeks. Subjects returned for evaluations at Week 2 (Visit 3), Week 4 (Visit 4), and Week 6 (Visit 5). At Week 6, subjects in the Regression group entered a 2-week regression period (no moisturizer usage) and returned for evaluations at Regression Days 1, 4, 7, 10, and 14. Meanwhile, at Week 6, subjects in the Non-Regression group (exploratory) continued using the moisturizers; they returned for evaluations at Week 6 + Days 1, 2, 3, and 4.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2020

First Posted

August 12, 2020

Study Start

October 23, 2015

Primary Completion

March 25, 2016

Study Completion

April 7, 2016

Last Updated

August 12, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share

Johnson \& Johnson Consumer Inc. has an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.

More information

Locations